Literature DB >> 16856154

Radiotherapy in the multimodal treatment of extrarenal extracranial malignant rhabdoid tumors.

Dev R Puri1, Paul A Meyers, Dennis H Kraus, Michael P Laquaglia, Leonard H Wexler, Suzanne L Wolden.   

Abstract

Extrarenal extracranial malignant rhabdoid tumors (MRT) are extremely rare and typically lethal. No consensus exists on an optimal treatment approach, and, in particular, the role of radiation therapy (RT) is poorly defined. We report on three children who underwent multimodality treatment including surgery, chemotherapy (CMT), and RT. Two of these patients are alive and without evidence of disease 6(1/2) and 7 years after diagnosis and one has expired. Our limited experience suggests that RT in the setting of CMT and surgery has the potential to prolong survival with acceptable toxicity, but outcomes are inconsistent and further study is necessary. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 16856154     DOI: 10.1002/pbc.20947

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  4 in total

1.  Epidemiology of rhabdoid tumors of early childhood.

Authors:  Julia E Heck; Christina A Lombardi; Myles Cockburn; Travis J Meyers; Michelle Wilhelm; Beate Ritz
Journal:  Pediatr Blood Cancer       Date:  2012-03-20       Impact factor: 3.167

2.  Extrarenal Extracranial Rhabdoid Tumor of the Pelvis in a Young Adult-management of a Challenging Case.

Authors:  Bharti Devnani; Ahitagni Biswas; Sameer Bakhshi; Seema Kaushal; Tripti Nakra
Journal:  Indian J Med Paediatr Oncol       Date:  2017 Jul-Sep

3.  Factors Affecting the Outcomes of Patients with Malignant Rhabdoid Tumors: A Population-Based Study.

Authors:  Wen Cai; Xue Liu; Weiting Ge; Dehao Wu; Junxi Xu; Rui Bai; Hanguang Hu
Journal:  Int J Med Sci       Date:  2021-01-01       Impact factor: 3.738

Review 4.  A Systematic Review and Meta-Analysis of Malignant Rhabdoid and Small Cell Undifferentiated Liver Tumors: A Rational for a Uniform Classification.

Authors:  Juri Fuchs; Anastasia Murtha-Lemekhova; Markus Kessler; Fabian Ruping; Patrick Günther; Alexander Fichtner; Dominik Sturm; Katrin Hoffmann
Journal:  Cancers (Basel)       Date:  2022-01-06       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.